desipramine has been researched along with Asthenia in 2 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Asthenia: Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alnaes, R | 1 |
| Carles Egea, F | 1 |
2 other studies available for desipramine and Asthenia
| Article | Year |
|---|---|
[Desipramine (Sertofren) in the treatment of depression].
Topics: Aged; Asthenia; Depression; Desipramine; Electroconvulsive Therapy; Female; Humans; Middle Aged; Tac | 1967 |
[Preliminary note on the use of desipramine in the ambulatory treatment of asthenia].
Topics: Asthenia; Desipramine; Humans | 1965 |